Latest Shareholder Approvals News

Brazilian Critical Minerals Limited reported a net cash outflow from operating activities in the December 2024 quarter but maintains a solid cash position supported by significant unused financing facilities.

InhaleRx has locked in a $38.5 million funding deal with Clendon Biotech Capital, enabling expanded Phase 2 trials for its inhaled breakthrough cancer pain and panic disorder treatments. The company also filed a key international patent, positioning itself for a faster path to FDA approval.

Javelin Minerals has completed Phase 1 drilling at its Coogee Gold Project with assay results pending, while finalizing the acquisition of the Eureka Gold Project and preparing for further drilling in early 2025.

Santana Minerals has reported a robust Pre-feasibility Study for its Bendigo-Ophir Gold Project, lifting the after-tax NPV to A$1.2 billion and IRR to 76%, as it progresses detailed engineering and fast-track permitting in New Zealand.

Bubalus Resources has appointed Brendan Borg as Managing Director, positioning the company to accelerate exploration at its Victorian Gold Projects amid a buoyant gold market.

Myer Holdings Limited is advancing a transformative merger with Premier Investments' Apparel Brands, aiming to create a $4 billion retail powerhouse. Shareholders overwhelmingly support the deal, which promises enhanced scale, diversified earnings, and strategic growth opportunities.

SelfWealth Limited reported a modest revenue increase for the half-year ended December 2024, yet profits plunged sharply due to higher operating expenses as the company prepares for a potential acquisition by Bell Financial Group.

Antipa Minerals reports robust progress at its Minyari Dome Gold-Copper Project, highlighted by a positive Scoping Study and promising Phase 2 drilling results, alongside a strengthened cash position of A$36.5 million following a strategic equity raise and asset sale.

Coppermoly Limited has raised $1.05 million through a share placement to fund its 2025 copper and gold exploration projects in Queensland’s Mt Isa and Cloncurry regions. The capital injection underscores the company’s commitment to advancing its resource portfolio in a highly prospective mining district.

Star Minerals secures shareholder approval for its Cobra Uranium Project in Namibia and prepares for maiden drilling, while progressing gold exploration in Western Australia amid a modest capital raise.

NeuRizer Ltd has completed a $150,000 private share placement, issuing 100 million new shares to support its NeuRizer Urea Project and general working capital needs.

Emyria Limited announces key leadership shifts with Greg Hutchinson stepping up as Executive Chairman and Dr. Michael Winlo transitioning to Chief Scientific Officer, aiming to scale innovative mental health therapies amid growing demand.